scorecard

You Searched For "SII" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Zoho to Zerodha, here are the 10 most valuable bootstrapped companies in India

In a world dominated by venture capital and large-scale investments, a select group of Indian compa…

Business Insider Latest Story Image
3 mins read

Should you be worried about the potential side-effects of the Covishield vaccine?

Thrombosis with Thrombocytopenia Syndrome (TTS), can lead to dangerously low blood clot and platele…

Business Insider Latest Story Image
2 mins read

Serum Institute's Covovax gets DCGI approval as a heterologous booster dose

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommende…

PTI   


Business Insider Latest Story Image
1 min read

Serum Institute applies to Indian authorities for full market authorisation of Covishield

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine t…

PTI   


Business Insider Latest Story Image
1 min read

Serum Institute of India seeks permission from DCGI to manufacture 'Sputnik V' COVID-19 vaccine in the country

Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories. …

PTI   


Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…

Business Insider Latest Story Image
2 mins read

India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates

The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …

Business Insider Latest Story Image
2 mins read

SII launches India's first indigenous pneumonia vaccine at $3 per dose

CEO Adar Poonawalla Roughly stated that SII’s pneumococcal conjugate vaccine will cost the gover…

Business Insider Latest Story Image
2 mins read

COVID-19 vaccine: SII and Bharat Biotech asked to submit more data for emergency approval

The Central Drugs Standard Control Organisation's Subject Expert Committee on Wednesday asked the S…

Business Insider Latest Story Image
3 mins read

Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI

SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…

PTI   


Business Insider Latest Story Image
1 min read

Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia

According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…

Business Insider Latest Story Image
1 min read

COVID-19 cases in India cross 32 lakh mark, recovery rate rises to 75.92%

With 67,151 fresh coronavirus infections in 24 hours, India's tally mounted to 32,34,474 on Wednesd…

Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine human trials to continue in India, says SII

The testing of Covid-19 vaccine being developed by AstraZeneca and University of Oxford has been pu…

Business Insider Latest Story Image
2 mins read

SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations

Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…

Business Insider Latest Story Image
2 mins read

Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market

SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…

Business Insider Latest Story Image
2 mins read

After SII's Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel

The authorisation was significant for India as the Pune-based Serum Institute of India had t…

Business Insider Latest Story Image
1 min read

DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis

"... the new coronavirus variant 'omicron' has already been reported in more than 60 countries and…

PTI   


Business Insider Latest Story Image
1 min read

SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an …

PTI   


Business Insider Latest Story Image
3 mins read

Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports

Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…

Business Insider Latest Story Image
1 min read

Exports of SII vaccine blocked till March-April

New Delhi, Jan 18 (IANS) Exports of the Oxford-AstraZeneca vaccine by the Serum Institute of India …